PREDXBIO Trademark

Trademark Overview


On Thursday, March 16, 2023, a trademark application was filed for PREDXBIO with the United States Patent and Trademark Office. The USPTO has given the PREDXBIO trademark a serial number of 97842648. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 20, 2024. This trademark is owned by SpIntellx, Inc.. The PREDXBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring web based pathology software, namely, web based image analysis software for use in the field of pathology; Software as a service (SAAS) services, featuring software for use in the field of pathology, namely, software that defines the spatial relationships between cells and molecules within tissue microenvironments to aid in the interpretation of patient tissue samples, predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; Software as a service (SAAS) services, featuring software for performing image analysis in the field of pathology, namely, in connection with transmitted light microscopy and fluorescence microscopy; Software as a service (SAAS) services, featuring software for reviewing and managing images and for digital pathology image management; Software as a service (SAAS) services, featuring software for use in cancer diagnosis, namely, software to predict metastatic potential in primary s...
predxbio

General Information


Serial Number97842648
Word MarkPREDXBIO
Filing DateThursday, March 16, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and ServicesSoftware as a service (SAAS) services featuring web based pathology software, namely, web based image analysis software for use in the field of pathology; Software as a service (SAAS) services, featuring software for use in the field of pathology, namely, software that defines the spatial relationships between cells and molecules within tissue microenvironments to aid in the interpretation of patient tissue samples, predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; Software as a service (SAAS) services, featuring software for performing image analysis in the field of pathology, namely, in connection with transmitted light microscopy and fluorescence microscopy; Software as a service (SAAS) services, featuring software for reviewing and managing images and for digital pathology image management; Software as a service (SAAS) services, featuring software for use in cancer diagnosis, namely, software to predict metastatic potential in primary solid tumors; Software as a service (SAAS) services, featuring web based software for viewing, annotating, analyzing, and scoring digital slides, for consolidating case information, a score, results, a diagnosis, comments, and digital images into a pathology case report, for generating, exporting, and printing pathology case reports, and for providing audit trials in the field of pathology; Software as a service (SAAS) services, featuring web based software for remotely accessing pathology images, for remotely accessing pathology images and metadata, and for creating, assigning, and managing pathology cases; Providing an online searchable database featuring images for evaluating machine learning algorithms for computational pathology, for scientific and medical research purposes; medical research, namely, pathology evaluations utilizing image analysis algorithms; Medical and scientific research in the field of cancer treatment and diagnosis and consultation related thereto; medical and scientific research in the field of medical imaging and consultation related thereto; Software as a service (SAAS) services, featuring computer software for use in image analysis of digital images of tissue samples acquired by optical microscopy; Software as a service (SAAS) services, featuring computer software for creating tissue-based image analysis algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; Software as a service (SAAS) services, featuring data processing software for tissue-based image analysis using algorithms; Software as a service, (SAAS) services, featuring data processing software for tissue-based image analysis using algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSpIntellx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15202

Party NameSpIntellx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15202

Trademark Events


Event DateEvent Description
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 16, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, January 16, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 16, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, January 16, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 13, 2023ASSIGNED TO EXAMINER
Friday, April 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 20, 2023NEW APPLICATION ENTERED